EIP Pharma
Cambridge, US · Founded 2018 · Delaware corporation
Founders & leadership
EIP Pharma was founded in 2018 by John Alam.
JA
John AlamFounder
TM
Tatjana MayNamed on SEC filing
SG
Sylvie GregoireNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$44.5M disclosed across 7 rounds · 2017–2023
▶$810KraisedJul 2023 · 2 investors · BiotechnologyRule 506(b)
▶$810KraisedJul 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JEFF POULTONDirector
- WILLIAM TURNERExecutive Officer
- SYLVIE GREGOIREDirector
- FRANK ZAVRLDirector
- KELLY BLACKBURNExecutive Officer
- JOHN ALAMExecutive Officer, Director
- MARWAN SABBAGHDirector
- Offering amount
- $810K
- Amount sold
- $810K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6MraisedDec 2021 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank ZavrlDirector
- Marwan SabbaghDirector
- Sylvie GregoireExecutive Officer, Director
- Jeff PoultonDirector
- John AlamExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $6M
- Minimum investment
- $1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5.1MraisedJan 2021 · 28 investors · Other Health CareRule 506(b)
▶$5.1MraisedJan 2021 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John AlamExecutive Officer, Director
- Sylvie GregoireDirector
- Tatjana MayDirector
- Jeff PoultonDirector
- Frank ZavrlDirector
- Noel DonnellyExecutive Officer
- Offering amount
- $10M
- Amount sold
- $5.1M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.7MraisedJan 2020 · 6 investors · Other Health CareRule 506(b)
▶$2.7MraisedJan 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John AlamExecutive Officer, Director
- Sylvie GregoireExecutive Officer, Director
- Tatjana MayDirector
- Jeff PoultonDirector
- Noel DonnellyExecutive Officer
- Frank ZavrlDirector
- Offering amount
- $4.5M
- Amount sold
- $2.7M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$9MraisedDec 2018 · 4 investors · Other Health CareRule 506(b)
▶$9MraisedDec 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tatjana MayDirector
- Jeff PoultonDirector
- Sylvie GregoireExecutive Officer, Director
- Frank ZavrlDirector
- John AlamExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $9M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$20.5MraisedApr 2018 · 3 investors · Other Health CareRule 506(b)
▶$20.5MraisedApr 2018 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tatjana MayDirector
- John AlamExecutive Officer, Director
- Sylvie GregoireExecutive Officer, Director
- Offering amount
- $20.5M
- Amount sold
- $20.5M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$400KraisedJan 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$400KraisedJan 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John AlamExecutive Officer
- Offering amount
- $4M
- Amount sold
- $400K
- Minimum investment
- $200K
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Massachusetts
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded EIP Pharma?
- EIP Pharma was founded by John Alam in 2018.
- How much funding has EIP Pharma raised?
- EIP Pharma has disclosed $44.5M raised across 7 rounds.
- Where is EIP Pharma headquartered?
- EIP Pharma is headquartered in Cambridge, US.